- 111, Inc. runs an online healthcare platform in China.
- The company’s main website receives 0.299 million visits per month and 6.73 pages per visit. 111, Inc. website receives more visits than the website of Ali Health.
- With forward 2021 sales of $2 billion, the company trades at 0.3x forward sales. In my view, 111, Inc. is extremely undervalued by the market.
- 111, Inc. is reducing losses and may soon reach profitability. Analysts believe that the company may show positive EBITDA and net income by 2021.
- The company has two types of shares, class A and class B. Thanks to this bad corporate governance practice, the founders control more than 90% of the total voting power.
For further details see:
111, Inc.: Cheap But Risky And Controlled By Founders